← Back to news
S

Seeking Alpha: News

Lilly says experimental obesity drug delivered weight loss across all stages of menopause

B

Goldman Sachs drops 2026 Fed cut call after strong jobs data

B

U.S. is said to push U.N. nuclear watchdog for answers from Iran on uranium

B

Bybit launches tokenized IPO platform with SpaceX debut

B

'Scary Movie' delivers franchise record opening as U.S. box office jumps 61%

S

Trump urges Fed to cut rates as strong jobs data fuels expectations of hike

S

Banks rethink hiring as AI shrinks entry-level roles, reshapes recruiting

B

Ingredion is said to near $3.6B deal for Tate & Lyle as London market loses another mainstay

B

Repair cafes gain momentum as consumers push back against throwaway culture

B

AI IPO wave could test Wall Street's appetite for new shares

S

Credit markets shrug off geopolitical turmoil as investors seek yield, SocGen says

S

AI World Cup predictions: the machines love France

S

How to trade the AI IPO boom without chasing the hype

B

Goldman Sachs: Signs of market exuberance are rising, but fall short of prior bubbles

S

Traders pricing in a rate hike by year end after jobs jump

S

Trump’s market sway keeps investors guessing, from oil to bonds

S

SA Asks: Will Tesla merge with SpaceX?

S

Airline profits forecast to halve in 2026 as Middle East conflict, fuel costs weigh

S

Partners Group co-founder calls share selloff excessive after fund withdrawal limits

B

Air France-KLM open to EasyJet talks as takeover interest builds

B

Valuation expert sees SpaceX worth $1.3T, below IPO target

B

Nvidia deepens SK Hynix partnership as AI infrastructure demand accelerates

S

United CEO blasts Rolls-Royce over contract dispute, questions supplier commitment

B

Quant snapshot: United Natural Foods, Designer Brands lead top-rated names as MIND Technology, BARK lag

B

OPEC+ approves another oil output increase for July, extends compliance deadline

B

Notable healthcare headlines for the week: UnitedHealth, Medtronic, and Eli Lilly in focus

B

Employers scale back coverage of weight-loss drugs as costs surge

B

Top global stories this week

B

Incyte nears $2B deal for blood disorder drug developer Star Therapeutics: FT

B

Rising gas prices push consumers to trim spending, hunt for bargains

B

OpenAI plans major ChatGPT overhaul ahead of expected IPO, FT reports

S

Trending stocks this week amid risk-off selloff on Wall Street

S

Earnings week ahead: ORCL, ADBE, FCEL, ACB, CHWY, and more

S

Lights, camera, algorithm: Hollywood's uneasy relationship with generative AI

S

French telecom rivals strike $23.5B deal to acquire SFR from Altice

B

Market momentum: The S&P 500 stocks that crushed it and crashed this week

S

Iran's oil exports sink to six-year lows amid U.S. naval blockade, analysts say

S

Riyadh Air receives first Boeing 787 Dreamliners ahead of service launch

S

Eli Lilly reports broad benefits for experimental obesity drug retatrutide

S

Key deals this week: Mobix Labs, MGM Resorts, Cloudflare, and more

S

Paramount is ready to divest kids’ channels to win EU for Warner deal: report

S

SpaceX IPO positioned for an oversubscription ‌rate of two times: Reuters

B

SA Asks: What's the most undervalued AI-adjacent stock right now?

S

Marvell and Flex set to replace Pool and Campbell’s in S&P 500

S

Real estate stocks shine as traders switch to defensives from tech

S

In-N-Out Burger: The hamburger chain with a cult following and simple model

S

Over $1T wiped out as chip selloff impacts Nvidia, Broadcom, Micron

S

Insider trades: Nvidia, Intel, Verizon among notable trades

S

SA Asks: Can Adobe thrive in the age of AI?

S

Pfizer says mid-stage trial data support monthly dosing for GLP-1 therapy

S